Le Lézard
Classified in: Environment, Science and technology
Subjects: Product/Service, Award

Wolters Kluwer wins Sustainable Service Award at 2024 SEAL Business Sustainability Awards


Wolters Kluwer, a global leader in information, software, and services for professionals, announces that its Enablon ESG Excellence solution has received a Sustainable Service Award at the 2024 SEAL Business Sustainability Awards.

SEAL (Sustainability, Environmental Achievement & Leadership) Awards is an environmental advocacy organization that honors leadership through its business sustainability awards and environmental journalism awards. The 2024 SEAL Business Sustainability Awards recognize companies for their industry leadership, innovation, and commitment to sustainable business practices.

Enablon ESG Excellence brings clarity to the complexity of ESG through harnessing advanced technologies to support and enable the end-to-end process of ESG reporting. Enablon is committed to continuous innovation of its client offering, which enables leaders to manage risk, drive sustainability and boost productivity across the entire value chain.

Laurent Dechaux, Senior Vice President and Managing Director, Enablon, Wolters Kluwer CP & ESG said: "As the ESG reporting landscape evolves, companies increasingly seek to adopt transformative technologies to meet the growing requirements of regulators, stakeholders, and customers. We are delighted that our cutting-edge ESG solution has won a Sustainable Service Award. Enablon ESG Excellence empowers sustainability and finance leaders to collaborate to collect, report, and disclose verifiable ESG data ? with the same rigor as they apply to financial data."

Enablon is part of Wolters Kluwer's Corporate Performance & ESG (CP & ESG) division. The division is the world's leading provider of integrated software solutions for EHS, Environmental, Social, and Governance (ESG), and Governance, Risk and Compliance (GRC). Through innovative technology and unique expertise, Wolters Kluwer CP & ESG enables business leaders to make informed, strategic decisions that drive transformation, performance, and risk management for a sustainable and resilient world.

For more information about Wolters Kluwer, please visit: www.wolterskluwer.com

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2023 annual revenues of ?5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: